Search results
Michael Rosenblatt, M.D., is a former chief medical officer at Merck and a board member of several Flagship companies. He has a long and distinguished career in biomedical research, education and innovation, and holds 19 patents and over 180 publications.
Dr. Rosenblatt is a physician, scientist, educator and leader in healthcare. He has worked in academia, pharmaceutical industry and biotech/venture, and served as Dean, CMO, and board member of several organizations.
Jul 13, 2016 · Cambridge, Mass., July 13, 2016 (PR Newswire) – Flagship Ventures today announced the appointment of industry veteran Michael Rosenblatt, M.D., to the new position of Chief Medical Officer. In this capacity, Dr. Rosenblatt will lead global clinical development and medical affairs for the organization.
Michael Rosenblatt, M.D., has held major leadership roles in academia and the biopharmaceutical industry, and currently serves as Senior Partner of Flagship Pioneering in Cambridge, MA. Dr. Rosenblatt was Chief Medical Officer (CMO) for Merck from 2009-2016. Earlier (his first of two times at Merck), he was SVP for Research at Merck Research ...
Michael Rosenblatt, MD ’73 Senior Advisor, Ascenta Capital; Senior Advisor, Bain Capital Life Sciences; Senior Advisor, Flagship Pioneering ...
Sep 29, 2016 · Michael Rosenblatt, newly appointed Chief Medical Officer of Flagship Ventures and former Chief Medical Officer at Merck & Co., discusses his move from industry to venture capital.
Jul 13, 2016 · CAMBRIDGE, Mass., July 13, 2016 /PRNewswire/ -- Flagship Ventures today announced the appointment of industry veteran Michael Rosenblatt, M.D., to the new position of Chief Medical Officer....
